Pediatric Oncology · Wilms Tumor

Biology, Genetics, and Associated Syndromes

At a Glance

Wilms tumor is a childhood kidney cancer that typically develops from leftover immature kidney cells called nephrogenic rests. While 90% of cases occur by chance, 10% are linked to genetic mutations (like WT1) or syndromes such as WAGR, Beckwith-Wiedemann, and Denys-Drash.

While most cases of Wilms tumor happen by chance, understanding the “why” behind the diagnosis often leads to the world of genetics. For many parents, learning about the biological origins of the tumor can help clarify why certain treatments or screening schedules are chosen.

The Biological “Misfire”

A Wilms tumor is essentially a biological “misfire” during a baby’s development in the womb. In a typically developing fetus, a group of immature cells called the nephrogenic blastema is responsible for building the kidneys ^[1]. Normally, these cells finish their job and disappear by the time a baby is born.

Sometimes, however, small clusters of these immature cells persist after birth. These leftover clusters are called nephrogenic rests ^[2]. While most rests never cause a problem, they have the potential to grow uncontrollably and turn into a Wilms tumor ^[3]. This is why Wilms tumor is called an “embryonal” tumor—it is made of the very same cells that were meant to build the kidney ^[1].

Sporadic vs. Syndromic Cases

Doctors generally categorize cases into two groups:

Sporadic (Isolated): This accounts for about 90% of cases. The tumor occurs “out of the blue” in a child who has no other health issues or family history of the disease ^[4]. These children usually develop the tumor around age 3 or 4 ^[5].
Syndromic: About 10% of children have an underlying genetic syndrome that makes them more likely to develop a Wilms tumor ^[4]. These children often develop tumors at an earlier age and are at a higher risk of developing tumors in both kidneys (bilateral disease) ^[6].

Major Genetic Players

Several key genes act as “instruction manuals” for kidney development. When these instructions are garbled (mutated), a tumor can form:

WT1 (Wilms Tumor 1): One of the most well-known genes involved. Mutations here are often linked to early-onset tumors and specific developmental syndromes ^[7]^[8].
11p15 (WT2): This isn’t a single gene but a region on chromosome 11. It involves “imprinting,” which is like a dimmer switch for genes. If the switch is stuck in the “on” position (activating the IGF2 growth gene), cells can grow too fast ^[9]^[10].
Other Genes: Researchers have also identified roles for genes like CTNNB1, AMER1 (formerly WTX), and TRIM28, which help regulate how kidney cells mature and divide ^[11]^[12]^[13].

Associated Genetic Syndromes

There are three main syndromes that doctors look for when a child is diagnosed with a Wilms tumor:

Syndrome	Key Features	Genetic Link
WAGR Syndrome	Wilms tumor, Aniridia (missing the colored part of the eye), Genitourinary issues, and a Range of developmental delays ^[14].	Deletion of the WT1 gene and nearby genes ^[15].
Beckwith-Wiedemann Spectrum (BWSp)	An overgrowth disorder where babies may be very large at birth, have a large tongue (macroglossia), or have one side of the body larger than the other (hemihypertrophy) ^[16].	Problems with the “switches” on chromosome 11p15 ^[17].
Denys-Drash Syndrome	Severe kidney disease occurring early in life, combined with genital differences (often appearing as “ambiguous” genitalia) ^[18].	Specific types of mutations in the WT1 gene ^[19].

Recognizing these syndromes is vital because it helps the medical team create a long-term plan to monitor your child’s other kidney and watch for other potential health issues ^[20]^[21].

Back to Home

Common questions in this guide

What are nephrogenic rests?

Nephrogenic rests are small clusters of immature cells that were supposed to build the kidneys before birth but remained after the baby was born. Most never cause problems, but they can sometimes grow uncontrollably and turn into a Wilms tumor.

Is Wilms tumor inherited or genetic?

About 90% of Wilms tumors are sporadic, meaning they occur by chance with no family history. However, about 10% of cases are linked to underlying genetic changes, such as mutations in the WT1 gene or chromosome 11p15, which can increase the risk of tumors in both kidneys.

What genetic syndromes are associated with Wilms tumor?

The three main syndromes linked to Wilms tumor are WAGR syndrome, Beckwith-Wiedemann Spectrum (BWSp), and Denys-Drash syndrome. Children with these conditions have a higher risk of developing kidney tumors and require specialized long-term monitoring.

Should my child have genetic testing for Wilms tumor?

Your medical team may recommend genetic testing to check for mutations in the WT1 gene or other markers, especially if your child has tumors in both kidneys or specific physical features. A pediatric genetic counselor can help your family navigate this process.

What is WAGR syndrome?

WAGR syndrome is a rare genetic condition involving Wilms tumor, aniridia (missing the colored part of the eye), genitourinary issues, and developmental delays. It is caused by the deletion of the WT1 gene and nearby genes.

Curated prompts to bring to your next appointment.

1.Does my child's tumor appear to be 'sporadic' or part of a genetic syndrome?
2.Were 'nephrogenic rests' found in the healthy tissue surrounding the tumor?
3.Should my child be tested for mutations in the WT1 gene or for imprinting defects on chromosome 11p15?
4.Does my child have any physical features, like hemihypertrophy or aniridia, that we should be aware of?
5.If this is a syndromic case, how does that change the screening schedule for the remaining kidney?
6.Is a referral to a pediatric genetic counselor recommended for our family?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (21)

1
Novel concept of Wilms' tumor development: involvement of pluripotential cells of ureteric bud.
Sarkany B, Kuthi L, Kovacs G
Human pathology 2023; (138()):34-40 doi:10.1016/j.humpath.2023.05.004.
PMID: 37209922
2
Bilateral Nephroblastomatosis With a Unilateral Wilms Tumor: A Case Report Highlighting Imaging Characteristics.
Naggar A, Assila S, Laasri K, et al.
Global pediatric health 2024; (11()):2333794X231224566 doi:10.1177/2333794X231224566.
PMID: 38223903
3
Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
Vujanić GM, Apps JR, Moroz V, et al.
Pediatric blood & cancer 2017; (64(11)) doi:10.1002/pbc.26547.
PMID: 28383760
4
Case Report: Autosomal dominant polycystic kidney disease and Wilms' tumor in infancy and childhood.
Zina D, Rosita K, Kristina Z, et al.
Frontiers in pediatrics 2024; (12()):1322142 doi:10.3389/fped.2024.1322142.
PMID: 38577638
5
A rare case of a Wilms tumor: case report.
Singer CE, Marinău LD, Coşoveanu CS, et al.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2018; (59(4)):1287-1292.
PMID: 30845314
6
Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
Whitworth J, Armstrong R, Maher ER
European journal of human genetics : EJHG 2024; (32(3)):361-364 doi:10.1038/s41431-024-01545-7.
PMID: 38282073
7
Early diagnosis of WT1 nephropathy and follow up in a Chinese multicenter cohort.
Sun S, Xu L, Bi Y, et al.
European journal of medical genetics 2020; (63(11)):104047 doi:10.1016/j.ejmg.2020.104047.
PMID: 32891756
8
New mutation in WT1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
Akramov NR, Shavaliev RF, Osipova IV
Medicine 2021; (100(19)):e25864 doi:10.1097/MD.0000000000025864.
PMID: 34106634
9
Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor.
Wegert J, Appenzeller S, Treger TD, et al.
Genome medicine 2025; (17(1)):49 doi:10.1186/s13073-025-01482-0.
PMID: 40340749
10
De novo paternal origin duplication of chromosome 11p15.5: report of two Chinese cases with Beckwith-Wiedemann syndrome.
Wang Q, Geng Q, Zhou Q, et al.
Molecular cytogenetics 2017; (10()):46 doi:10.1186/s13039-017-0347-z.
PMID: 29270226
11
NCYM facilitates cell proliferation and invasion in Wilms tumor by regulating SIX1/β-catenin axis.
Wang Z, Ning F, Tu L, et al.
American journal of clinical and experimental urology 2025; (13(5)):316-331 doi:10.62347/MVNT6272.
PMID: 41278306
12
TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ, Hoyer J, Ekici AB, et al.
International journal of cancer 2019; (145(4)):941-951 doi:10.1002/ijc.32167.
PMID: 30694527
13
Osteopathia striata with cranial sclerosis: a new case supporting the link with bilateral Wilms tumor.
Sinibaldi L, Micalizzi A, Serra A, et al.
European journal of human genetics : EJHG 2022; (30(3)):262-264 doi:10.1038/s41431-021-01035-0.
PMID: 35042990
14
Bilateral aniridia and congenital ureteral valve: Role of genetic testing.
Shields LBE, Peppas DS, Rosenberg E
Molecular genetics & genomic medicine 2020; (8(4)):e1183 doi:10.1002/mgg3.1183.
PMID: 32056389
15
A Chromosomal Microarray Detects Microdeletion at Chromosome Locus 11p14.3-p12 Leading to Wilms Tumor, Aniridia, Genitourinary Anomalies, and Mental Retardation (WAGR) Syndrome.
Majjigudda RA, Menon P, Gupte S, et al.
Cureus 2024; (16(10)):e72479 doi:10.7759/cureus.72479.
PMID: 39600756
16
Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice.
Eggermann T, Maher ER, Kratz CP, Prawitt D
Cancers 2022; (14(13)) doi:10.3390/cancers14133083.
PMID: 35804856
17
Improving the prenatal diagnosis of Beckwith-Wiedemann syndrome.
Van den Veyver IB
Prenatal diagnosis 2021; (41(7)):795-797 doi:10.1002/pd.5971.
PMID: 34008861
18
Case Report: Denys-Drash Syndrome With WT1 Causative Variant Presenting as Atypical Hemolytic Uremic Syndrome.
Cheng C, Chen L, Wen S, et al.
Frontiers in pediatrics 2020; (8()):605889 doi:10.3389/fped.2020.605889.
PMID: 33392118
19
Immune-complex glomerulonephritis with a membranoproliferative pattern in Frasier syndrome: a case report and review of the literature.
Matsuoka D, Noda S, Kamiya M, et al.
BMC nephrology 2020; (21(1)):362 doi:10.1186/s12882-020-02007-0.
PMID: 32838737
20
Wilms tumor and associated predisposing syndromes and conditions.
Meni D
JAAPA : official journal of the American Academy of Physician Assistants 2025; (38(1)):27-33 doi:10.1097/01.JAA.0000000000000165.
PMID: 39654521
21
Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.
Kalish JM, Becktell KD, Bougeard G, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2024; (30(23)):5260-5269 doi:10.1158/1078-0432.CCR-24-2100.
PMID: 39320341

This page provides educational information about the biology and genetics of Wilms tumor. It does not replace professional medical advice. Always consult your pediatric oncologist or a genetic counselor regarding your child's specific diagnosis and screening needs.

Get notified when new evidence is published on Nephroblastoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents